OpenAI’s ChatGPT Health adds a HIPAA-compliant wrapper over its regular models but delivers no new technology and raises doubts about data use and fine-tuning. It feels like another marketing stunt as Big Tech probes the healthcare market without real change.

• ChatGPT Health is just a HIPAA-compliant wrapper on existing models—no new underlying technology despite the marketing push.
• OpenAI's promise not to "train" on patient data leaves open whether they still fine-tune on it behind closed doors, echoing 23andMe's fine-print bait-and-switch on DNA data.
• This fits a pattern: AI Consult was human-curated ChatGPT, HealthBench was just a dataset, and GPT-5's health story was retracted amid lawsuits—all flash, no substance.
• The real goal is likely market-testing healthcare economics to undercut purpose-built HIPAA-compliant competitors, using hype to gauge demand before committing.

ChatGPT Health may be a marketing strategy rather than a genuine innovation, potentially allowing tech giants to dominate the healthcare sector. The article questions OpenAI's claims of enhanced security and adherence to HIPAA standards, drawing parallels to past controversies with data privacy in the tech industry.

• OpenAI's claims of HIPAA compliance and enhanced security for ChatGPT Health may be more marketing spin than substantive privacy protection
• The move could let a tech giant leverage user trust to gain a dominant foothold in the healthcare data market
• The situation echoes past tech industry controversies over data privacy, raising skepticism about the sincerity of OpenAI's promises